Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation

Biology of Reproduction

Volumn 88, Issue 6, 2013, Pages

  Hackbart, Katherine S ^a   Cunha, Pauline M ^a   Meye, Rudelle K ^a   Wiltbank, Milo C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dexamethasone; Follicle; Follicular development; Glucocorticoid; Hypothalamus; Ovary; Ovulation

Indexed keywords

DEXAMETHASONE; ESTRADIOL; GLUCOSE; GONADORELIN; INSULIN; LUTEINIZING HORMONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANOVULATION; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; COW; ESTROGEN RELEASE; FEMALE; HORMONE ACTION; INSULIN RESISTANCE; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; PROGESTERONE RELEASE;

DEXAMETHASONE; FOLLICLE; FOLLICULAR DEVELOPMENT; GLUCOCORTICOID; HYPOTHALAMUS; OVARY; OVULATION;

ANIMALS; BLOOD GLUCOSE; CATTLE; DEXAMETHASONE; ESTRADIOL; FEMALE; GLUCOCORTICOIDS; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; INSULIN RESISTANCE; LUTEINIZING HORMONE; OVARIAN FOLLICLE; OVULATION; PROGESTERONE;

EID: 84882288472     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.107862     Document Type: Article

References (81)

1. March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010; 25: 544-551.
2. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004; 89: 453-462.
3. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006; 91:2-6.
4. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004; 59:141-154.
5. Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update. 2006; 12:351-361.
6. Tok EC, Ertunc D, Evruke C, Dilek S. The androgenic profile of women with non-insulin-dependent diabetes mellitus. J Reprod Med. 2004; 49: 746-752.
7. Lujan ME, Kepley AL, Chizen DR, Lehotay DC, Pierson RA. Development of morphologically dominant follicles is associated with fewer metabolic disturbances in amenorrheic women with polycystic ovary syndrome: a pilot study. Ultrasound Obstet Gynecol. 2010; 36: 759-766.
8. Souza FAC, Dias R, Fernandes CE, Pimentel F, Dias D. Menstrual irregularity: a possible clinical marker of metabolic dysfunction in women with class III obesity. Gynecol Endocrinol. 2010; 26:768-772.
9. Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertil Steril. 2004; 81:624-629.
10. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?. Hum Reprod. 2003; 18:598-603.
11. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003; 88: 5957-5962.
12. Dewailly D, Catteau-Jonard S, Reyss AC, Maunoury-Lefebvre C, Poncelet E, Pigny P. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod. 2007; 22:1562-1566.
13. Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril. 2007; 87:870-875.
14. Weinstein SP, Paquin T, Pritsker A, Haber RS. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes. 1995; 44:441-445.
15. Shpigel NY, Chen R, Avidar Y, Bogin E. Use of corticosteroids alone or combined with glucose to treat ketosis in dairy cows. J Am Vet Med Assoc. 1996; 208(10):1702-1704.
16. Nicod N, Giusti V, Besse C, Tappy L. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes Res. 2003; 11:625-631.
17. Patel JV, Cummings DE, Girod JP, Mascarenhas AV, Hughes EA, Gupta M, Lip GY, Reddy S, Brotman DJ. Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment. J Negat Results Biomed. 2006; 5:14.
18. Coderre L, Vallega GA, Pilch PF, Chipkin SR. Regulation of glycogen concentration and glycogen synthase activity in skeletal muscle of insulinresistant rats. Arch Biochem Biophys. 2007; 464:144-150.
19. Maciel SM, Chamberlain CS, Wettemann RP, Spicer LJ. Dexamethasone influences endocrine and ovarian function in dairy cattle. J Dairy Sci. 2001; 84:1998-2009.
20. Rhee MS, Perianayagam A, Chen P, Youn JH, McDonough AA. Dexamethasone treatment causes resistance to insulin-stimulated cellular potassium uptake in the rat. Am J Physiol Cell Physiol. 2004; 287: C1229-C1237.
21. Qi D, Pulinilkunnil T, An D, Ghosh S, Abrahani A, Pospisilik JA, Brownsey R, Wambolt R, Allard M, Rodrigues B. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. Diabetes. 2004; 53: 1790-1797.
22. Frautschy SA, Liptrap RM. Anovulation and plasma-hormone concentrations after administration of dexamethasone during the middle of the luteal phase in sows undergoing estrous cycles. Am J Vet Res. 1988; 49: 1270-1275.
23. Dunshea FR, Harris DM, Bauman DE, Boyd RD, Bell AW. Effect of porcine somatotropin on in vivo glucose kinetics and lipogenesis in growing pigs. J Anim Sci. 1992; 70:141-151.
24. Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER. Influence of growth hormone on glucose-glucose 6- phosphate cycle and insulin action in normal humans. Am J Physiol. 1992; 263:E980-E987.
25. Kim JK, Choi CS, Youn JH. Acute effect of growth hormone to induce peripheral insulin resistance is independent of FFA and insulin levels in rats. Am J Physiol. 1999; 277:E742-E749.
26. Park MJ, Jung SR, Jung HL, Craig BW, Lee CD, Kang HY. Effects of 4 weeks recombinant human growth hormone administration on insulin resistance of skeletal muscle in rats. Yonsei Med J. 2008; 49:1008-1016.
27. Hammon HM, Philipona C, Zbinden Y, Blum JW, Donkin SS. Effects of dexamethasone and growth hormone treatment on hepatic gluconeogenic enzymes in calves. J Dairy Sci. 2005; 88:2107-2116.
28. Ginther OJ, Wiltbank MC, Fricke PM, Gibbons JR, Kot K. Selection of the dominant follicle in cattle. Biol Reprod. 1996; 55:1187-1194.
29. Ginther OJ, Beg MA, Bergfelt DR, Donadeu FX, Kot K. Follicle selection in monovular species. Biol Reprod. 2001; 65:638-647.
30. Sartori R, Haughian JM, Shaver RD, Rosa GJM, Wiltbank MC. Comparison of ovarian function and circulating steroids in estrous cycles of Holstein heifers and lactating cows. J Dairy Sci. 2004; 87:905-920.
31. Haughian JM, Ginther OJ, Kot K, Wiltbank MC. Relationships between FSH patterns and follicular dynamics and the temporal associations among hormones in natural and GnRH-induced gonadotropin surges in heifers. Reproduction. 2004; 127:23-33.
32. Siddiqui MA, Gastal EL, Gastal MO, Almamun M, Beg MA, Ginther OJ. Relationship of vascular perfusion of the wall of the preovulatory follicle to in vitro fertilisation and embryo development in heifers. Reproduction. 2009; 137:689-697.
33. Palhao MP, Beg MA, Rodrigues MT, Ginther OJ. Follicle and hormone dynamics in single versus double ovulating heifers. Reproduction. 2009; 138:561-570.
34. Karkalas J. An improved enzymic method for the determination of native and modified starch. J Sci Food Agric. 1985; 36:1019-1027.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-419.
36. Cassuto H, Kochan K, Chakravarty K, Cohen H, Blum B, Olswang Y, Hakimi P, Xu C, Massillon D, Hanson RW, Reshef L. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem. 2005; 280:33873-33884.
37. Lange AJ, Argaud D, el-Maghrabi MR, Pan W, Maitra SR, Pilkis SJ. Isolation of a cDNA for the catalytic subunit of rat liver glucose-6- phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun. 1994; 201:302-309.
38. Schmoll D, Allan BB, Burchell A. Cloning and sequencing of the 50 region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells. FEBS Lett. 1996; 383:63-66.
39. Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID. Mechanisms of insulin-induced insulin-receptor downregulation: decrease of receptor biosynthesis and mRNA levels. Diabetes. 1989; 38:182-187.
40. Buren J, Liu HX, Lauritz J, Eriksson JW. High glucose and insulin in combination cause insulin receptor substrate-1 and 2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes. Eur J Endocrinol. 2003; 148:157-167.
41. Renstrom F, Buren J, Svensson M, Eriksson JW. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Metabolism. 2007; 56: 190-198.
42. Yi CX, Foppen E, Abplanalp W, Gao Y, Alkemade A, la Fleur SE, Serlie MJ, Fliers E, Buijs RM, Tschop MH, Kalsbeek A. Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes. 2012; 61:339-345.
43. Morgan SA, Sherlock M, Gathercole LL, Lavery GG, Lenaghan C, Bujalska IJ, Laber D, Yu A, Convey G, Mayers R, Hegyi K, Sethi JK, et al. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoidinduced insulin resistance in skeletal muscle. Diabetes. 2009; 58: 2506-2515.
44. Kuo T, Lew MJ, Mayba O, Harris CA, Speed TP, Wang JC. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc Natl Acad Sci U S A. 2012; 109:11160-11165.
45. De Paula FM, Boschero AC, Carneiro EM, Bosqueiro JR, Rafacho A. Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid. Biol Res. 2011; 44:251-257.
46. Lowenberg M, Tuynman J, Scheffer M, Verhaar A, Vermeulen L, van Deventer S, Hommes D, Peppelenbosch M. Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Endocrinology. 2006; 147:3555-3562.
47. Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod. 1998; 4:1-8.
48. Naessen T, Kushnir MM, Chaika A, Nosenko J, Mogilevkina I, Rockwood AL, Carlstrom K, Bergquist J, Kirilovas D. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry. Fertil Steril. 2010; 94:2228-2233.
49. Sander VA, Hapon MB, Sicaro L, Lombardi EP, Jahn GA, Motta AB. Alterations of folliculogenesis in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2011; 124:58-64.
50. Bider D, Pariente C, Dor J, Zolti M, Mashiach S, Ben-Rafael Z. Aromatase activity of human granulosa cells in patients with polycystic ovaries treated with dexamethasone. Fertil Steril. 1990; 54:597-600.
51. Gaon D, Liptrap RM. Effect of dexamethasone on secretion of luteinizing hormone and testosterone in the boar. Theriogenology. 1989; 32:79-85.
52. Breen KM, Davis TL, Doro LC, Nett TM, Oakley AE, Padmanabhan V, Rispoli LA, Wagenmaker ER, Karsch FJ. Insight into the neuroendocrine site and cellular mechanism by which cortisol suppresses pituitary responsiveness to gonadotropin-releasing hormone. Endocrinology. 2008; 149:767-773.
53. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor-I and insulin. Fertil Steril. 1993; 59:323-331.
54. Nahum R, Thong KJ, Hillier SG. Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod. 1995; 10:75-81.
55. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998; 83:2001-2005.
56. Garzo VG, Dorrington JH. Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin. Am J Obstet Gynecol. 1984; 148:657-662.
57. Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow. Gynecol Endocrinol. 2001; 15:142-149.
58. Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002; 77:141-146.
59. Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?. J Clin Endocrinol Metab. 2010; 95:810-819.
60. Daghestani MH, El-Mazny A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol. 2011; 155:65-68.
61. Yanagimoto T, Itoh S, Muller-Enoch D, Kamataki T. Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. Biochim Biophys Acta. 1992; 1130:329-332.
62. Mate ML, Lifschitz A, Sallovitz J, Ballent M, Muscher AS, Wilkens MR, Schroder B, Lanusse C, Virkel G. Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone-treated sheep. J Vet Pharmacol Ther. 2012; 35:319-328.
63. Pascussi JM, Drocourt L, Fabre JM, Maurel P, Vilarem MJ. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol. 2000; 58: 361-372.
64. Meunier V, Bourrie M, Julian B, Marti E, Guillou F, Berger Y, Fabre G. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up. Xenobiotica. 2000; 30:589-607.
65. Lemley CO, Butler ST, Butler WR, Wilson ME. Short communication: insulin alters hepatic progesterone catabolic enzymes cytochrome P450 2C and 3A in dairy cows. J Dairy Sci. 2008; 91:641-645.
66. Lemley CO, Wilmoth TA, Tager LR, Krause KM, Wilson ME. Effect of a high cornstarch diet on hepatic cytochrome P450 2C and 3A activity and progesterone half-life in dairy cows. J Dairy Sci. 2010; 93:1012-1021.
67. Hasegawa Y, Kishimoto S, Shibatani N, Inotsume N, Takeuchi Y, Fukushima S. Effects of insulin on CYP3A activity and nicardipine disposition in streptozotocin-induced diabetic rats. J Pharm Pharmacol. 2010; 62:883-889.
68. Gumen A, Wiltbank MC. An alteration in the hypothalamic action of estradiol due to lack of progesterone exposure can cause follicular cysts in cattle. Biol Reprod. 2002; 66:1689-1695.
69. Gumen A, Sartori R, Costa FM, Wiltbank MC. A GnRH/LH surge without subsequent progesterone exposure can induce development of follicular cysts. J Dairy Sci. 2002; 85:43-50.
70. Wiltbank MC, Gumen A, Sartori R. Physiological classification of anovulatory conditions in cattle. Theriogenology. 2002; 57:21-52.
71. Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor: correlation to their glucocorticoid- like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol. 1983; 32:1511-1518.
72. Sugino N, Telleria CM, Gibori G. Progesterone inhibits 20alphahydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor. Endocrinology. 1997; 138:4497-4500.
73. Madauss KP, Deng SJ, Austin RJ, Lambert MH, McLay I, Pritchard J, Short SA, Stewart EL, Uings IJ, Williams SP. Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. J Med Chem. 2004; 47:3381-3387.
74. Issar M, Sahasranaman S, Buchwald P, Hochhaus G. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur Respir. J 2006; 27:511-516.
75. Wagenmaker ER, Breen KM, Oakley AE, Pierce BN, Tilbrook AJ, Turner AI, Karsch FJ. Cortisol interferes with the estradiol-induced surge of luteinizing hormone in the ewe. Biol Reprod. 2009; 80:458-463.
76. Smith RF, Ghuman SP, Evans NP, Karsch FJ, Dobson H. Stress and the control of LH secretion in the ewe. Reprod Suppl. 2003; 61:267-282.
77. Breen KM, Karsch FJ. New insights regarding glucocorticoids, stress and gonadotropin suppression. Front Neuroendocrinol. 2006; 27:233-245.
78. Dobson H, Fergani C, Routly JE, Smith RF. Effects of stress on reproduction in ewes. Anim Reprod Sci. 2012; 130:135-140.
79. Oakley AE, Breen KM, Clarke IJ, Karsch FJ, Wagenmaker ER, Tilbrook AJ. Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: influence of ovarian steroids. Endocrinology. 2009; 150:341-349.
80. Fergani C, Saifullizam AK, Routly JE, Smith RF, Dobson H. Estrous behavior, luteinizing hormone and estradiol profiles of intact ewes treated with insulin or endotoxin. Physiol Behav. 2012; 105:757-765.
81. Breen KM, Karsch FJ. Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level?. Endocrinology. 2004; 145: 692-698